US-based private equity firm Advent International has agreed to invest Rs 2,475 crore ($296 million) to pick up a minority stake in Apollo HealthCo Ltd, ..
Advent International, a global private equity firm, Thursday announced the plan to merge two of its pharmaceutical portfolio companies, Cohance Lifesciences Ltd and Suven Pharmaceuticals ..
Promoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significant stake in Suven Pharma. Under the merger, shareholders of Cohance will be issued 11 shares of Suven Pharma for every 295 shares held by the former. The new shares of Suven will be traded on the NSE and BSE.
HYDERABAD: Following the acquisition of Hyderabad-based Suven Pharma last year, global private equity giant Advent International is now merging the un.